Helix BioPharma Corp.: Helix Biopharma Corp. Closes Private

RICHMOND HILL, ON / ACCESSWIRE / March 11, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology

Related Keywords

Canada , Toronto , Ontario , Richmond Hill , Canadian , Frank Michalargias , Alpha Bronze , Toronto Stock Exchange , Helix Biopharma Corp , Incentive Program , Helix Biopharma , Incentive Plan , Jerzy Wilczewski , Interim Chief Executive , Multilateral Instrument , Minority Security Holders , Special Transactions , Eligible Warrants , Incentive Exercise Price , Extended Warrants , Warrant Extension , Chief Financial , Looking Statements , Chief Executive , Annual Information Form , Helix , Iopharma , Orp , Loses , Private , Placement , Nnounces , Early , Warrant , Exercise , Incentive , Program , Extension , Eriod ,